LI-COR Biosciences recently presented two posters detailing research and development of two new IRDyeŽ infrared dye optical agents for cancer research. IRDye 800CW 2DG, a near infrared metabolic optical imaging agent, can be used for studying tumor biology in mice. The IRDye 680 Bone Marker, an effective bone labeling for in vivo NIR noninvasive imaging in nude mice, makes it possible to visualize bone anatomy/structures for an extended period and facilitates use of the bone targeting agent in conjunction with a second optical agent specific for a primary target (i.e, tumor tissue).
|
1-866-720-8052